These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 33671917)

  • 1. The Role of NK Cells in EBV Infection and EBV-Associated NPC.
    Png YT; Yang AZY; Lee MY; Chua MJM; Lim CM
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33671917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
    Viet NH; Trung NQ; Dong LT; Trung LQ; Espinoza JL
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):713-723. PubMed ID: 33392659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
    Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
    mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon beta increases NK cell cytotoxicity against tumor cells in patients with nasopharyngeal carcinoma via tumor necrosis factor apoptosis-inducing ligand.
    Makowska A; Franzen S; Braunschweig T; Denecke B; Shen L; Baloche V; Busson P; Kontny U
    Cancer Immunol Immunother; 2019 Aug; 68(8):1317-1329. PubMed ID: 31312900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBV-Upregulated B7-H3 Inhibits NK cell-Mediated Antitumor Function and Contributes to Nasopharyngeal Carcinoma Progression.
    Chen H; Duan X; Deng X; Huang Y; Zhou X; Zhang S; Zhang X; Liu P; Yang C; Liu G; Ren Q; Xiong Y; Zhu B; Zhang J; Xiang T
    Cancer Immunol Res; 2023 Jun; 11(6):830-846. PubMed ID: 36996321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for EBV-Associated Nasopharyngeal Carcinoma.
    Hong M; Tang K; Qian J; Deng H; Zeng M; Zheng S; Ding K; Du Y; Sun R
    Crit Rev Oncog; 2018; 23(3-4):219-234. PubMed ID: 30311576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus Epithelial Cancers-A Comprehensive Understanding to Drive Novel Therapies.
    Han S; Tay JK; Loh CJL; Chu AJM; Yeong JPS; Lim CM; Toh HC
    Front Immunol; 2021; 12():734293. PubMed ID: 34956172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus infection and nasopharyngeal carcinoma.
    Tsao SW; Tsang CM; Lo KW
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients.
    Shen Y; Zhang S; Sun R; Wu T; Qian J
    Emerg Microbes Infect; 2015 Mar; 4(3):e20. PubMed ID: 26038769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.
    Tsang CM; Tsao SW
    Virol Sin; 2015 Apr; 30(2):107-21. PubMed ID: 25910483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapeutic approaches in nasopharyngeal carcinoma.
    Chow JC; Ngan RK; Cheung KM; Cho WC
    Expert Opin Biol Ther; 2019 Nov; 19(11):1165-1172. PubMed ID: 31361154
    [No Abstract]   [Full Text] [Related]  

  • 12. High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma.
    Coghill AE; Bu W; Nguyen H; Hsu WL; Yu KJ; Lou PJ; Wang CP; Chen CJ; Hildesheim A; Cohen JI
    Clin Cancer Res; 2016 Jul; 22(14):3451-7. PubMed ID: 26920891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma.
    Li W; Duan X; Chen X; Zhan M; Peng H; Meng Y; Li X; Li XY; Pang G; Dou X
    Front Immunol; 2022; 13():1079515. PubMed ID: 36713430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic active Epstein-Barr virus infection].
    Kimura H
    Uirusu; 2011 Dec; 61(2):163-73. PubMed ID: 22916563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation.
    Duan X; Chen H; Zhou X; Liu P; Zhang X; Zhu Q; Zhong L; Zhang W; Zhang S; Zhang X; Chen Y; Zhou Y; Yang C; Feng Q; Zeng YX; Xu M; Xiang T
    Cancer Res; 2022 Mar; 82(6):1070-1083. PubMed ID: 35064016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.
    Zheng XH; Lu LX; Li XZ; Jia WH
    Cancer Sci; 2015 Sep; 106(9):1196-201. PubMed ID: 26082292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis.
    Hsu WL; Chien YC; Huang YT; Yu KJ; Ko JY; Lin CY; Tsou YA; Leu YS; Liao LJ; Chang YL; Su JY; Liu Z; Wang CP; Terng SD; Hua CH; Lee JC; Yang TL; Kate Hsiao CH; Wu MS; Tsai MH; Liu MJ; Lou PJ; Hildesheim A; Chen CJ;
    Cancer Med; 2020 Mar; 9(5):1867-1876. PubMed ID: 31925935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma.
    Hui KF; Chan TF; Yang W; Shen JJ; Lam KP; Kwok H; Sham PC; Tsao SW; Kwong DL; Lung ML; Chiang AKS
    Int J Cancer; 2019 Jun; 144(12):3031-3042. PubMed ID: 30536939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma.
    Renaud S; Lefebvre A; Mordon S; Moralès O; Delhem N
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between environmental factors and serological Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma in South China.
    Zhou T; Yang DW; He YQ; Xue WQ; Liao Y; Zheng MQ; Jia YJ; Yuan LL; Zhang WL; Zeng YX; Jia WH
    Cancer Med; 2019 Aug; 8(10):4852-4866. PubMed ID: 31241250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.